Experimental therapeutic studies of Solanum aculeastrum Dunal. on Leishmania major infection in BALB/c mice

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 89

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_IJBMS-18-1_010

تاریخ نمایه سازی: 4 آبان 1400

Abstract:

Objective(s):Solanum acueastrum Dunal.has been shown to have some chemotherapeutic value. Leaf and berry water and methanol compounds of S. acueastrum were evaluated for possible antileishmanial activity In vivo on BALB/c mice and in vitro against Leishmania major promastigotes, amastigotes and vero cells.  Materials and Methods: Dry S. aculeastrum berry and leaf material were extracted in methanol and water. L. major parasites were exposed to different concentrations of S. aculeastrum fruit and leaf compounds and the IC۵۰ on the promastigotes, percentage of infection rate of macrophages by amastigotes and the toxicological effect on vero cells were determined. BALB/c mice were infected subcutaneously with ۱×۱۰۶ promastigotes and kept for four weeks to allow for disease establishment. Infected mice were treated with fruit and leaf methanolic and water compounds, amphotericin B (AmB), and sterile phosphate buffered saline (PBS). Results: Fruit methanol compound was most effective in inhibiting the growth of promastigotes with IC۵۰۷۸.۶۲ μg/ml. Fruit water compound showed the best activity in inhibiting infection of macrophages by amastigotes. Fruit methanol compound was more toxic at Ld۵۰=۸.۰۶ mg/ml to vero cells than amphotericin B. Analysis of variance computation indicated statistically significant difference in lesion sizes between experimental and control mice groups (P=۰.۰۰۰۱). Splenic impression smears ANOVA indicated a highly significant difference in parasitic numbers between the experimental and the control groups (P=۰.۰۰۰۱). Conclusion: The results demonstrate that compounds from S. aculeastrum have potential anti-leishmanial activities and the medicinal use of the plant poses considerable toxicity against dividing vero cells.

Authors

Linet T Laban

Department of Zoological Sciences, Kenyatta University, ۴۳۸۴۴ – ۰۰۱۰۰, Nairobi, Kenya

Christopher O Anjili

Kenya Medical Research Institute, ۵۴۸۴۰-۰۰۲۰۰, Nairobi, Kenya

Joshua M Mutiso

Department of Zoological Sciences, Kenyatta University, ۴۳۸۴۴ – ۰۰۱۰۰, Nairobi, Kenya

Johnstone Ingonga

Kenya Medical Research Institute, ۵۴۸۴۰-۰۰۲۰۰, Nairobi, Kenya

Samuel G Kiige

Department of Zoological Sciences, Kenyatta University, ۴۳۸۴۴ – ۰۰۱۰۰, Nairobi, Kenya

Mgala M Ngedzo

Department of Zoological Sciences, Kenyatta University, ۴۳۸۴۴ – ۰۰۱۰۰, Nairobi, Kenya

Michael M Gicheru

Department of Zoological Sciences, Kenyatta University, ۴۳۸۴۴ – ۰۰۱۰۰, Nairobi, Kenya

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Pezeshkpoor F, Rezaei AR, Shirdel A, Khajedaluee M, Alizadeh M, ...
  • Kimutai A, Ngure PK, Tonui KW, Gicheru MM, Nyamwamu LB. ...
  • Ghosh A, Zhang WW, Matlashewski G. Immunization with A۲ protein ...
  • World Health Organization (WHO). The selection and use of essential ...
  • Emami SA, Rabe SZT, Ahi A, Mahmoud M. Inhibitory activity ...
  • Chavoshian O, Biari N, Badiee A , Khamesipour A, Abbasi ...
  • World Health Organization (WHO). Leishmaniasis: background information. A brief history ...
  • Ngure PK, Tonui, WK, Ingonga J, Mutai M, Kigondu E, ...
  • World Health Organization (WHO). Control of the leishmaniases. Technical report ...
  • ۱۰.Bryceson A. Therapy in man. In: Peters W, Killick-Kendrick R, ...
  • ۱۱.Tonui WK. Perspective. Situational analysis of leishmaniases research in Kenya. ...
  • ۱۲.Bryceson ADM, Diffuse cutaneous leishmaniasis. II. Treatment. Trans R Soc ...
  • ۱۳.Sazgarnia A, Zabolinejad N, Layegh P, Rajabi O, Benenji F, ...
  • ۱۴.Monzote L. Current treatment of leishmaniasis: A review. Open Antimicrob ...
  • ۱۵.World Health Organization/Tropical Disease Research (WHO/TDR). Scientific working group meeting ...
  • ۱۶.Manuel JC, Luis MP. Plant natural products with leishmanicidal activity. ...
  • ۱۷.World Health Organization/Tropical Disease Research (WHO/TDR). Leishmaniasis - disease information; ...
  • Koduru S, Grierson DS, Afolayan AJ. Ethnobotanical information of medicinal ...
  • ۱۹.Aboyade OM, Yakubu MT, Grierson DS, Afolayan AJ. Safety evaluation ...
  • ۲۰.Aboyade OM, Yakubu MT, Grierson DS, Afolayan AJ. Safety evaluation ...
  • ۲۱.Kokwaro JO. Medicinal plants of East Africa. Nairobi: East African ...
  • ۲۲.Koduru S, Grierson DS, Van de Venter M, Afolayan AJ. ...
  • ۲۳.Koduru S, Asekun OT, Grierson DS, Afolayan AJ. Isolation of ...
  • ۲۴.Wanyonyi AW, Tarus PK, Chhabra SC. A novel glycosidic steroidal ...
  • ۲۵.Wanyonyi AW, Chhabra SC, Mkoji G, Udo E, Njue WN. ...
  • ۲۶.Nfi AN, Ndi C, Bayemi HP, Njiwe R, Tchoumboue J, ...
  • ۲۷.Wabwoba B, Anjili CO, Ngeiywa MM, Ngure PK, Kigondu EM, ...
  • ۲۸.Dorin D, Le Roch K, Sallicandro P. Pfnek-۱, a NIMA ...
  • ۲۹.Mosmann T. Rapid colrimetric assay for cellular growth and survival: ...
  • ۳۰.Derolenzi JC, Attias M, Gattass, CR, Andrade M, Rezende C, ...
  • ۳۱.Berman JD, Lee LS. Activity of antileishmanial agents against amastigotes ...
  • ۳۲.Koduru S, Grierson DS, Van de Venter M, Afolayan AJ. ...
  • ۳۳.Ncube NS, Afoayan AJ, Okoh AI. Assessment techniques of antimicrobial ...
  • ۳۴.Lees P, Cunningham FM, Elliott J. Principles of pharmacodynamics and ...
  • ۳۵.Koduru S, Grierson DS, Aderogba MA, Eloff JN, Afolayan AJ. ...
  • نمایش کامل مراجع